Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Satsuma Pharmaceuticals, Inc. (STSA) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $32.19 Metrics
OS: 33.2 M
Market cap: $1.07 B
Net cash: $41.4 M $1.25 per share
EV: $1.03 B

 
TTM Valuation
EBITDA ($60.6) M
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
Revenues0.00.00.00.00.0
Cost of goods sold0.00.00.00.00.0
Gross profit0.00.00.00.00.0
Research and development37.636.324.26.44.2
General and administrative13.512.14.71.10.8
EBIT-51.2-48.3-28.9-7.5-4.9
Pre-tax income-51.2-47.6-28.2-7.3-5.2
Income taxes0.00.00.00.00.0
            Tax rate0.0%0.0%   
Net income-51.2-47.6-28.2-7.3-5.2
 
Diluted EPS($1.75)($2.73)($4.80)($7.15)($9.26)
Shares outstanding (diluted)29.217.45.91.00.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy